AUC passes, Cmax fails: biopharmaceutical difference [PK / PD]

posted by akif – Turkey, 2021-03-24 17:59 (1184 d 23:38 ago) – Posting: # 22293
Views: 1,730

Merhaba Helmut :)

Thank you

Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,665 registered users;
33 visitors (0 registered, 33 guests [including 5 identified bots]).
Forum time: 18:38 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz